Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - New York Stock Exchange, Inc. - FR0013467479 - Common Stock - Currency: USD

13.3  -0.06 (-0.45%)

After market: 13.3 0 (0%)

Fundamental Rating

5

CSTM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. While CSTM is still in line with the averages on profitability rating, there are concerns on its financial health. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
In the past year CSTM had a positive cash flow from operations.
CSTM had positive earnings in 4 of the past 5 years.
CSTM had a positive operating cash flow in each of the past 5 years.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CSTM's Return On Assets of 3.41% is fine compared to the rest of the industry. CSTM outperforms 70.78% of its industry peers.
The Return On Equity of CSTM (23.63%) is better than 93.51% of its industry peers.
CSTM has a Return On Invested Capital of 12.50%. This is amongst the best in the industry. CSTM outperforms 91.56% of its industry peers.
CSTM had an Average Return On Invested Capital over the past 3 years of 8.33%. This is below the industry average of 11.67%.
The last Return On Invested Capital (12.50%) for CSTM is above the 3 year average (8.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROIC 12.5%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

CSTM has a better Profit Margin (1.33%) than 62.99% of its industry peers.
CSTM's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.03%, CSTM perfoms like the industry average, outperforming 53.90% of the companies in the same industry.
CSTM's Operating Margin has declined in the last couple of years.
CSTM has a Gross Margin (11.88%) which is in line with its industry peers.
CSTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

3

2. Health

2.1 Basic Checks

CSTM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CSTM has been reduced compared to 1 year ago.
Compared to 5 years ago, CSTM has more shares outstanding
CSTM has a worse debt/assets ratio than last year.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CSTM has an Altman-Z score of 3.31. This indicates that CSTM is financially healthy and has little risk of bankruptcy at the moment.
CSTM has a better Altman-Z score (3.31) than 62.34% of its industry peers.
A Debt/Equity ratio of 2.56 is on the high side and indicates that CSTM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.56, CSTM is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Altman-Z 3.31
ROIC/WACC1.5
WACC8.36%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CSTM has a Current Ratio of 1.24. This is a normal value and indicates that CSTM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CSTM (1.24) is worse than 77.92% of its industry peers.
CSTM has a Quick Ratio of 1.24. This is a bad value and indicates that CSTM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, CSTM is doing worse than 88.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.17%.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
The Revenue has grown by 81.94% in the past year. This is a very strong growth!
CSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%

3.2 Future

CSTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.72% yearly.
Based on estimates for the next years, CSTM will show a quite strong growth in Revenue. The Revenue will grow by 14.03% on average per year.
EPS Next Y178.67%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue Next Year11.65%
Revenue Next 2Y11.82%
Revenue Next 3Y14.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.18, which indicates a rather expensive current valuation of CSTM.
69.48% of the companies in the same industry are more expensive than CSTM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CSTM to the average of the S&P500 Index (26.98), we can say CSTM is valued inline with the index average.
With a Price/Forward Earnings ratio of 8.22, the valuation of CSTM can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSTM indicates a rather cheap valuation: CSTM is cheaper than 82.47% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. CSTM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 24.18
Fwd PE 8.22
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CSTM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSTM is cheaper than 92.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.48
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSTM has a very decent profitability rating, which may justify a higher PE ratio.
CSTM's earnings are expected to grow with 69.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)7.41
EPS Next 2Y98.45%
EPS Next 3Y69.72%

More info and screens

0

5. Dividend

5.1 Amount

CSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSTELLIUM SE

NYSE:CSTM (6/30/2025, 5:05:01 PM)

After market: 13.3 0 (0%)

13.3

-0.06 (-0.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-23 2025-07-23/bmo
Inst Owners95.64%
Inst Owner Change-2.11%
Ins Owners1.83%
Ins Owner ChangeN/A
Market Cap1.90B
Analysts84
Price Target17.6 (32.33%)
Short Float %2.14%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-337.89%
Min EPS beat(2)-952.86%
Max EPS beat(2)277.07%
EPS beat(4)2
Avg EPS beat(4)-181.55%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-114.34%
EPS beat(12)3
Avg EPS beat(12)-87.57%
EPS beat(16)6
Avg EPS beat(16)-7.76%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.76%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)5
Avg Revenue beat(12)-0.54%
Revenue beat(16)9
Avg Revenue beat(16)1.13%
PT rev (1m)0%
PT rev (3m)-8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.25%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-14.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.16%
Revenue NY rev (1m)-4.14%
Revenue NY rev (3m)-5.92%
Valuation
Industry RankSector Rank
PE 24.18
Fwd PE 8.22
P/S 0.14
P/FCF N/A
P/OCF 6.39
P/B 2.55
P/tB 3.14
EV/EBITDA 4.48
EPS(TTM)0.55
EY4.14%
EPS(NY)1.62
Fwd EY12.17%
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)2.08
OCFY15.65%
SpS92.34
BVpS5.21
TBVpS4.23
PEG (NY)0.14
PEG (5Y)7.41
Profitability
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROCE 15.83%
ROIC 12.5%
ROICexc 12.96%
ROICexgc 13.54%
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score8
Asset Turnover2.55
Health
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 134.34%
Cap/Sales 3.07%
Interest Coverage 6.05
Cash Conversion 35.72%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.53
Altman-Z 3.31
F-Score8
WACC8.36%
ROIC/WACC1.5
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
EPS Next Y178.67%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%
Revenue Next Year11.65%
Revenue Next 2Y11.82%
Revenue Next 3Y14.03%
Revenue Next 5YN/A
EBIT growth 1Y39.57%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year102.52%
EBIT Next 3Y37.28%
EBIT Next 5YN/A
FCF growth 1Y-191.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.16%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%